FEATURED

Everyone expects TSMC to beat on revenue when it reports Q2 2026 results on July 16. The stock is up roughly 45% year-to-date. Analysts have been raising targets. The AI infrastructure spending cycle is intact. The obvious read: strong demand, strong numbers, stock keeps going.

That framing is mostly right and mostly useless. The more interesting question entering this earnings report is not whether TSMC beats on the $39.0-$40.2 billion revenue guidance. It is whether the margin structure holds at 66% gross margins while a $52-56 billion capital expenditure program ramps simultaneously, and whether management can credibly guide H2 without spooking the market on 2-nanometer dilution.

That tension is where the real trade lives.

What Q1 Actually Showed

TSMC’s Q1 2026 results were extraordinary by any reasonable standard. Revenue reached $35.9 billion, up 40.6% year-over-year in U.S. dollar terms and slightly above the company’s own guidance range of $34.6-35.8 billion. Gross margin came in at 66.2%, operating margin at 58.1%, net margin at 50.5%. These are numbers that would be remarkable for a software company. For a capital-intensive foundry operating at the frontier of sub-3nm physics, they are almost implausible.

The 3-nanometer process accounted for 25% of wafer revenue in Q1, and high-performance computing reached 61% of total revenue, up sharply from prior quarters. Management guided that 3nm gross margins would cross over to corporate average levels in the second half of 2026. If that crossover materializes on schedule, it removes one of the more persistent bear arguments about N3 being a margin drag.

For Q2, TSMC guided revenue between $39.0 and $40.2 billion with gross margins of 65.5-67.5% and operating margins of 56.5-58.5%. Both came in above analyst consensus at the time of guidance. Management also revised its full-year AI accelerator revenue CAGR guidance upward from 50% to a mid-to-high 50s range (approximately 56-59%), explicitly citing Agentic AI demand as the driver of incremental capacity investment. Full-year 2026 revenue is expected to grow above 30% in U.S. dollar terms.

The Capex Question Nobody Is Asking Cleanly

Here is where it gets more complicated. TSMC’s 2026 capital expenditure guidance sits at $52-56 billion, with 70-80% directed toward advanced process technologies. Management guided toward the high end of that range on the Q1 call. The Arizona fab build-out is accelerating. A new 3nm fab is being added to the Tainan Science Park cluster. The scale of the U.S. footprint is growing materially, with TSMC expanding fab capacity across multiple Arizona sites.

That capex scale creates two legitimate risks entering July 16. First, management flagged 2-3% gross margin dilution expected from the 2-nanometer ramp and overseas expansion in 2026. The CFO acknowledged H2 headwinds explicitly on the Q1 call. The market accepted that commentary in April when gross margins were running above guidance. The question is whether the same tolerance holds if Q2 gross margins come in at the low end of the 65.5-67.5% guidance range.

Second, fixed-cost underutilization risk is real at this capex level. TSMC’s entire bull case rests on AI infrastructure spending remaining elevated through 2027. If hyperscaler capex guidance shows any softness in the coming weeks, the committed spending becomes a liability rather than a moat signal. The company has acknowledged this directly: if global AI hardware spending experiences any cyclical deceleration, TSMC is highly exposed to fixed-cost underutilization. Worth sitting with that for a moment.

The Valuation Anomaly Worth Noting

At a current price around $434, TSMC’s trailing P/E ratio sits near 36x. The peer average across comparable semiconductor companies is approximately 44.6x. One valuation framework puts a fair P/E multiple at around 61.8x based on TSMC’s growth profile, margins, size, and risk factors. That is nearly double the current trailing multiple.

The discount reflects the geopolitical risk premium that every investor in this stock has to underwrite. Taiwan Strait tensions, U.S.-China export control escalation, customer concentration risk, and the complexity of a simultaneous global manufacturing buildout. Those are real risks. But the valuation gap between where TSMC trades and where comparable businesses trade is harder to justify the more the Arizona footprint grows. The average 12-month analyst price target sits near $488-$490, implying roughly 12-13% upside from current levels. Seventeen of eighteen covering analysts rate TSM as Buy or Strong Buy.

Goldman Sachs removed TSM from its APAC Conviction List on July 1, citing tactical reassessment of near-term upside. That is worth noting as a short-term caution, not a thesis-level concern. Combined April and May 2026 revenue came in at roughly 24% year-over-year growth, trailing analyst expectations of approximately 35% for the full Q2 period. That gap drove the early July pullback and is part of what Goldman cited.

What July 16 Actually Decides

High-performance computing is now 61% of TSMC revenue. AI demand continues to push past smartphones as the dominant mix driver. According to TrendForce Q1 2026 data, TSMC holds approximately 72.3% global foundry market share while Samsung sits at 6.5%. That gap is not narrowing. Samsung’s persistent challenges at advanced nodes continue to push customers toward TSMC’s capacity, and the company ended Q1 with cash and marketable securities of approximately $106 billion.

The 28% dividend increase for 2026 signals management confidence in free cash flow generation. The 2026 earnings consensus sits near $15.25 per share, implying approximately 43% growth year-over-year. Full-year 2026 revenue consensus is approximately $161.7 billion, up 32% from 2025. Those are not modest numbers for a company already generating 50%+ net margins.

The combined April and May revenue growth of roughly 24% year-over-year trailed Wall Street’s elevated expectations heading into Q2. That gap fed the early July pullback. If Q2 comes in at or above $39.5 billion with gross margins holding at 66%, the H1 growth deceleration story gets quietly abandoned and H2 guidance becomes the conversation. If margins disappoint or H2 guidance is cautious on 2nm dilution, the stock faces a more uncomfortable re-rating into the back half of the year.

The question is not whether TSMC is the dominant AI infrastructure foundry. It clearly is, with 72.3% global foundry market share and no credible alternative for sub-3nm production at volume. The question is whether the margin story at $56 billion in annual capex is as clean as Q1 made it look.

July 16 answers that.

For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.